FUJIFILM BiosciencesFUJIFILM Biosciences
FB

FUJIFILM Biosciences

A division of FUJIFILM Corporation focused on providing services and solutions for the biopharmaceutical industry.

Inactive504

About

FUJIFILM Biosciences is a part of FUJIFILM Corporation, leveraging its parent company's extensive expertise in areas like imaging, materials science, and drug discovery to offer services and solutions to the biopharmaceutical sector. This includes contract development and manufacturing (CDMO) services, as well as specialized reagents and technologies for drug discovery and development. The company collaborates with other entities, such as Virica Biotech, to advance biopharmaceutical innovation.

Technology stack

detected 2026-05-23
Est. monthly stack spend~$1,790/mo
CDN
AWS CloudFront
EmailProofpoint
gateway-fronted
Hosting
self_managed
Cookie consent
OneTrust
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does FUJIFILM Biosciences do?

FUJIFILM Biosciences is a part of FUJIFILM Corporation, leveraging its parent company's extensive expertise in areas like imaging, materials science, and drug discovery to offer services and solutions to the biopharmaceutical sector. This includes contract development and manufacturing (CDMO) services, as well as specialized reagents and technologies for drug discovery and development. The company collaborates with other entities, such as Virica Biotech, to advance biopharmaceutical innovation.

Where is FUJIFILM Biosciences headquartered?

FUJIFILM Biosciences is headquartered in Greenville, South Carolina, USA.

What industry does FUJIFILM Biosciences operate in?

FUJIFILM Biosciences operates in Biotechnology, Pharmaceuticals, Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO).

How many employees does FUJIFILM Biosciences have?

FUJIFILM Biosciences has approximately 504 people on record.

What is FUJIFILM Biosciences's current status?

FUJIFILM Biosciences's current operating status is: Inactive.